182
Participants
Start Date
July 10, 2017
Primary Completion Date
July 3, 2020
Study Completion Date
September 29, 2020
SER-109
"SER-109 is an ecology of bacteria in spore form, enriched from stool donations obtained from healthy, screened donors~Other Names:~Eubacterial Spores, Purified Suspension, Encapsulated"
Placebo
Placebo will be identical to the investigational product but will not contain product spores or non-spore solids. Placebo will consist of 92% glycerol and 8% normal saline(0.9%).
(Investigator site), Buffalo
(Investigator site), Pittsburgh
(Investigator site), Sayre
(Investigator site), Washington D.C.
(Investigator site), Reston
(Investigator site), Chevy Chase
(Investigator site), Annapolis
(Investigator site), Charlottesville
(Investigator site), Raleigh
(Investigator site), Greenville
(Investigator site), Kinston
(Investigator site), Marietta
(Investigator site), Riverdale
(Investigator site), Atlanta
(Investigator site), Sandy Springs
(Investigator site), Athens
(Investigator site), Jacksonville
(Investigator site), Miami
(Investigator site), Pembroke Pines
(Investigator site), Pembroke Pines
(Investigator site), Miami
(Investigator site), Columbus
(Investigator site), Cleveland
(Investigator site), Centerville
(Investigator site), Jeffersonville
(Investigator site), Evansville
(Investigator site), Royal Oak
(Investigator site), Detroit
(Investigator site), Iowa City
(Investigator site), Butte
(Investigator site), Springfield
(Investigator site), St Louis
(Investigator site), Kansas City
(Investigator site), New Orleans
(Investigator site), North Little Rock
(Investigator site), Southlake
(Investigator site), Houston
(Investigator site), San Antonio
(Investigator site), Idaho Falls
(Investigator site), Bountiful
(Investigator site), Riverton
(Investigator site), Las Vegas
(Investigator site), Northridge
(Investigator site), Upland
(Investigator site), Simi Valley
(Investigator site), Mountain View
(Investigator site), Mather
(Investigator site), Sacramento
(Investigator site), Hamden
(Investigator site), Boston
(Investigator site), Worcester
(Investigator site), Calgary
(Investigator site), Vancouver
(Investigator site), Victoria
(Investigator site), London
(Investigator site), Chicoutimi
Seres Therapeutics, Inc.
INDUSTRY